SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-23-050844
Filing Date
2023-11-01
Accepted
2023-11-01 16:21:58
Documents
17
Period of Report
2023-10-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20013742_8k.htm   iXBRL 8-K 56229
2 EXHIBIT 10.1 ef20013742_ex10-1.htm EX-10.1 135825
3 EXHIBIT 10.2 ef20013742_ex10-2.htm EX-10.2 64938
4 EXHIBIT 10.3 ef20013742_ex10-3.htm EX-10.3 2925
5 EXHIBIT 99.1 ef20013742_ex99-1.htm EX-99.1 18815
9 image0.jpg GRAPHIC 6484
  Complete submission text file 0001140361-23-050844.txt   483461

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA ocup-20231030.xsd EX-101.SCH 3865
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE ocup-20231030_lab.xml EX-101.LAB 22546
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ocup-20231030_pre.xml EX-101.PRE 16044
11 EXTRACTED XBRL INSTANCE DOCUMENT ef20013742_8k_htm.xml XML 4087
Mailing Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335
Business Address 37000 GRAND RIVER AVE. SUITE 120 FARMINGTON HILLS MI 48335 248-681-9815
Ocuphire Pharma, Inc. (Filer) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34079 | Film No.: 231368561
SIC: 2834 Pharmaceutical Preparations